20.33 USD
+0.07 (+0.35%)
20.33 USD
0 (0%)
Taking everything into account, SLP scores 6 out of 10 in our fundamental rating. SLP was compared to 35 industry peers in the Health Care Technology industry. While SLP has a great health rating, its profitability is only average at the moment. SLP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- SLP had positive earnings in the past year.
- SLP had a positive operating cash flow in the past year.
- Of the past 5 years SLP 4 years were profitable.
- SLP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- SLP has a Return On Assets of -46.61%. This is in the lower half of the industry: SLP underperforms 68.57% of its industry peers.
- With a Return On Equity value of -50.54%, SLP perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
- With a decent Return On Invested Capital value of 4.45%, SLP is doing good in the industry, outperforming 74.29% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.63%.
- The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROIC | 4.45% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
- With an excellent Operating Margin value of 9.00%, SLP belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
- SLP's Operating Margin has declined in the last couple of years.
- SLP's Gross Margin of 59.60% is in line compared to the rest of the industry. SLP outperforms 51.43% of its industry peers.
- SLP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SLP is destroying value.
- SLP has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, SLP has more shares outstanding
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 23.74 indicates that SLP is not in any danger for bankruptcy at the moment.
- The Altman-Z score of SLP (23.74) is better than 97.14% of its industry peers.
- There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 23.74 |
ROIC/WACC0.46
WACC9.72%
2.3 Liquidity
- A Current Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 5.62, SLP belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
- A Quick Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 5.62, SLP belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 50.00% over the past year.
- SLP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.07% yearly.
- The Revenue has been growing slightly by 5.69% in the past year.
- Measured over the past years, SLP shows a quite strong growth in Revenue. The Revenue has been growing by 13.74% on average per year.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
- The Earnings Per Share is expected to grow by 22.12% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 10.39% on average over the next years. This is quite good.
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- SLP is valuated quite expensively with a Price/Earnings ratio of 33.88.
- 71.43% of the companies in the same industry are more expensive than SLP, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of SLP to the average of the S&P500 Index (27.38), we can say SLP is valued slightly more expensively.
- With a Price/Forward Earnings ratio of 20.89, SLP is valued on the expensive side.
- Based on the Price/Forward Earnings ratio, SLP is valued a bit cheaper than 77.14% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, SLP is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.88 | ||
| Fwd PE | 20.89 |
4.2 Price Multiples
- SLP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SLP is cheaper than 62.86% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 77.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.55 | ||
| EV/EBITDA | 25.63 |
4.3 Compensation for Growth
- SLP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.05
PEG (5Y)31.73
EPS Next 2Y29.52%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
- SLP has a yearly dividend return of 0.61%, which is pretty low.
- SLP's Dividend Yield is rather good when compared to the industry average which is at 0.54. SLP pays more dividend than 94.29% of the companies in the same industry.
- With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
20.33
+0.07 (+0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-01 2026-04-01
Inst Owners79.38%
Inst Owner Change0.02%
Ins Owners17.2%
Ins Owner Change-0.18%
Market Cap409.45M
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Analysts80
Price Target24.23 (19.18%)
Short Float %6.9%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.28%
Min EPS beat(2)-77.15%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)71.31%
Min EPS beat(4)-77.15%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)23.48%
EPS beat(12)5
Avg EPS beat(12)8.75%
EPS beat(16)7
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.77%
Max Revenue beat(2)1.36%
Revenue beat(4)4
Avg Revenue beat(4)1.01%
Min Revenue beat(4)0.63%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.57%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)0.08%
PT rev (1m)3.26%
PT rev (3m)-6.25%
EPS NQ rev (1m)-17.01%
EPS NQ rev (3m)37.85%
EPS NY rev (1m)88.82%
EPS NY rev (3m)82.04%
Revenue NQ rev (1m)1.69%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0.6%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.88 | ||
| Fwd PE | 20.89 | ||
| P/S | 5.2 | ||
| P/FCF | 20.55 | ||
| P/OCF | 17.32 | ||
| P/B | 3.22 | ||
| P/tB | 7.5 | ||
| EV/EBITDA | 25.63 |
EPS(TTM)0.6
EY2.95%
EPS(NY)0.97
Fwd EY4.79%
FCF(TTM)0.99
FCFY4.87%
OCF(TTM)1.17
OCFY5.77%
SpS3.91
BVpS6.31
TBVpS2.71
PEG (NY)1.05
PEG (5Y)31.73
Graham Number9.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROCE | 5.55% | ||
| ROIC | 4.45% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 29.44% | ||
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% | ||
| FCFM | 25.32% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 50.91% | ||
| Cap/Sales | 4.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 164.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 | ||
| Altman-Z | 23.74 |
F-Score6
WACC9.72%
ROIC/WACC0.46
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y33.64%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.92%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y53.44%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.52%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to grow by 32.34% in the next year.